Simplex Trading, LLC F Star Therapeutics, Inc. Transaction History

Simplex Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$5.41 - $6.74 $45,319 - $56,460	-8,377 Reduced 96.1%	340 $1,000
Q2 2022 Aug 03, 2022	BUY	$2.18 - $6.39 $19,003 - $55,701	8,717 New	8,717 $54,000
Q1 2022 May 02, 2022	SELL	$2.77 - $5.36 $6,553 - $12,681	-2,366 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$4.71 - $7.38 $11,143 - $17,461	2,366 New	2,366 $11,000

44.7K

Ticker FSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,584,700
Description
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.